{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "B cell",
      "HLA",
      "Immunogenetic marker",
      "Luminex",
      "NGS",
      "Next-generation sequencing",
      "SARS-COV-2",
      "T cell"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35838957",
  "DateCompleted": {
    "Year": "2022",
    "Month": "07",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "08",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1007/978-1-0716-2395-4_10"
    ],
    "Journal": {
      "ISSN": "1940-6029",
      "JournalIssue": {
        "Volume": "2511",
        "PubDate": {
          "Year": "2022"
        }
      },
      "Title": "Methods in molecular biology (Clifton, N.J.)",
      "ISOAbbreviation": "Methods Mol Biol"
    },
    "ArticleTitle": "SARS-CoV-2 Host Immunogenetic Biomarkers.",
    "Pagination": {
      "StartPage": "133",
      "EndPage": "147",
      "MedlinePgn": "133-147"
    },
    "Abstract": {
      "AbstractText": [
        "SARS-CoV-2 causes generally mild symptoms, with approximately 10-20% of cases progressing to severe disease. The pathophysiologic mechanisms by which SARS-CoV-2 causes severe disease are largely unknown. Data have indicated the involvement of different immunogenetic markers such as HLA, T, and B cells, to be associated with disease outcome. This has led to interest in these genes as potential biomarkers of SARS-CoV-2 susceptibility and for predicting prognosis and response to vaccines and other therapeutic strategies. In this chapter, we discussed outline protocols for characterizing these potential biomarkers and methods for identifying SARS-CoV-2 biomarkers using the Luminex<sup>\u00ae</sup> 100/200 technology and next-generation sequencing."
      ],
      "CopyrightInformation": "\u00a9 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. Maemu.gededzha@nhls.ac.za."
          },
          {
            "Identifier": [],
            "Affiliation": "National Health Laboratory Services, Johannesburg, South Africa. Maemu.gededzha@nhls.ac.za."
          }
        ],
        "LastName": "Gededzha",
        "ForeName": "Maemu P",
        "Initials": "MP"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."
          },
          {
            "Identifier": [],
            "Affiliation": "National Health Laboratory Services, Johannesburg, South Africa."
          }
        ],
        "LastName": "Mampeule",
        "ForeName": "Nakampe",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."
          },
          {
            "Identifier": [],
            "Affiliation": "National Health Laboratory Services, Johannesburg, South Africa."
          }
        ],
        "LastName": "Gandini",
        "ForeName": "Anastasia",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa."
          },
          {
            "Identifier": [],
            "Affiliation": "National Health Laboratory Services, Johannesburg, South Africa."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Immunology, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."
          }
        ],
        "LastName": "Mayne",
        "ForeName": "Elizabeth S",
        "Initials": "ES"
      }
    ],
    "GrantList": [
      {
        "GrantID": "U24 HG007438",
        "Acronym": "HG",
        "Agency": "NHGRI NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Methods Mol Biol",
    "NlmUniqueID": "9214969",
    "ISSNLinking": "1064-3745"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Biomarkers"
    },
    {
      "QualifierName": [
        "diagnosis"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "High-Throughput Nucleotide Sequencing"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunogenetics"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ]
}